Abstract B009: Phase I clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients

2016 ◽  
Author(s):  
Jonathan F. Head ◽  
Gregory A. Daniels ◽  
Michelle McKinney ◽  
Weg Ongkeko ◽  
Kyoko Sakamoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Cancer Patients ◽  
Cancer Vaccine ◽  
Phase I Clinical Trial ◽  
Recurrent Prostate Cancer ◽  
Gm Csf

A phase 1 clinical trial of a PSA/IL-2/GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e14584-e14584 ◽  
Author(s):  
Gregory A. Daniels ◽  
Michelle McKinney ◽  
Weg Ongkeko ◽  
Jessica Wang-Rodriguez ◽  
Kyoko Sakamoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Cancer Patients ◽  
Cancer Vaccine ◽  
Phase 1 ◽  
Recurrent Prostate Cancer ◽  
Phase 1 Clinical Trial ◽  
Gm Csf

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial

The Prostate ◽  
2006 ◽  
Vol 66 (8) ◽  
pp. 811-821 ◽  
Author(s):  
Susanne Fuessel ◽  
Axel Meye ◽  
Marc Schmitz ◽  
Stefan Zastrow ◽  
Clemens Linné ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Dendritic Cells ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Clinical Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document